HRES 403 · 117th Congress · Congress

Providing for consideration of the bill (H.R. 1629) to amend the Federal Food, Drug, and Cosmetic Act with respect to limitations on exclusive approval or licensure of orphan drugs, and for other purposes; providing for consideration of the resolution (H. Res. 275) condemning the horrific shootings in Atlanta, Georgia, on March 16, 2021, and reaffirming the House of Representative's commitment to combating hate, bigotry, and violence against the Asian-American and Pacific Islander community; and for other purposes.

Introduced 2021-05-17· Sponsored by Rep. Scanlon, Mary Gay [D-PA-5]· House

Bill Progress

Introduced
Committee
House Vote
4
Senate
5
Enacted
Latest: Motion to reconsider laid on the table Agreed to without objection.(2021-05-18)

Recorded Votes

PassedHouse · 2021-05-18
Roll #147
Yea 212Nay 206
Democrats
212 Yea·0 Nay
Republicans
0 Yea·206 Nay
PassedHouse · 2021-05-18
Roll #147
Yea 212Nay 206
Democrats
212 Yea·0 Nay
Republicans
0 Yea·206 Nay
PassedHouse · 2021-05-18
Roll #146
Yea 217Nay 209
Democrats
217 Yea·0 Nay
Republicans
0 Yea·209 Nay

How Did Your Rep Vote?

Enter a ZIP code or representative's name

Plain Language Summary

[AI summary unavailable — showing source text] Sets forth the rule for consideration of the bill (H.R. 1629) to amend the Federal Food, Drug, and Cosmetic Act with respect to limitations on exclusive approval or licensure of orphan drugs, and for other purposes; providing for consideration of the resolution (H. Res. 275) condemning the horrific shootings in Atlanta, Georgia, on March 16, 2021, and reaffirming the House of Representative's commitment to combating hate, bigotry, and violence against the Asian-American and Pacific Islander community.…

Summarized by Claude AI · Non-partisan · For informational purposes only